Keywords

• Sofosbuvir
• CAS : 1190307-88-0
• 1190307-88-0

Quick Details

• ProName: Medicine Grade CAS1190307-88-0 Sofos...
• CasNo: 1190307-88-0
• Molecular Formula: C22H29FN3O9P
• Appearance: white powder
• Application: Animal Pharmaceuticals
• DeliveryTime: within 2-3 day
• PackAge: carton boc
• Port: tianjin/qingdao/shanghai
• ProductionCapacity: 1000000 Kilogram/Month
• Purity: 99%
• Storage: cool and dry
• Transportation: ship,fly
• LimitNum: 1 Gram
• Heavy metal: 1
• Grade: Industrial Grade
• 1: 100

Superiority

Hebei Mojin Biotechnology Co., Ltd,Our business covers more than 30 countries, most of the big customers come from Europe, America and other countries in the world, we can guarantee the quality and price. In recent decades, with the efforts of all employees, we have established many cooperative companies in shandong, henan, guangdong and other places. Our corporate purpose is based on the market, enhance the strength, take the road of scientific and environmental sustainable development, relying on the country. Technology r & d center, increase the investment in r & d, based on the domestic market, expand the international market, manufacturing quality products, sincere service to the society, into a modern, ecological, scientific and technological enterprise world.

Adenosine triphosphate can be used in the disease caused by tissue injury and activity reduction of ecto enzyme , including heart failure, carditis, miocardial infarction, cerebral arteriosclersis, coronary sclerosis, progressive muscular atrophy , cerebral hemorrhage , chronic hepatitis, cirrhosis of liver and hearing handicap, etc.

Details

Product Detailed

Sofosbuvir is a new drug candidate for hepatitis C treatment, Previously known as PS-7977 or GS-7977, it has shown promising results in numerous in vitro studies against all the genotypes of HCV. It is a nucleotide analog that is a highly potent inhibitor of the NS5B polymerase in HCV. This drug has shown high efficacy in combination with several other drugs with and without PEG-INF, against HCV. Sofosbuvir is of special interest among the directly acting antiviral drugs under development, due to its high potency, low side effects, oral administration, and high barrier to resistance.

Product picture 

Packing &shipping&Payment

Payment:T/T,,moneygram
Packaging Details drum
Port:Tianjin
Lead Time :

Advantage
In stock